Covina, Aug. 13, 2024 (GLOBE NEWSWIRE) -- According to Prophecy Market Insights, the global NGS-based RNA-sequencing market size and share is projected to grow from USD 2.1 Billion in 2024 and is forecasted to reach USD 11.1 Billion by 2034, exhibiting a compound annual growth rate (CAGR) of 18.10% during the forecast period (2024 - 2034).
NGS-Based RNA-Sequencing Market Report Overview
NGS-based RNA sequencing is a cutting-edge technology that has revolutionized the study of gene expression and transcriptomics. This method leverages the capabilities of NGS to provide a comprehensive and detailed analysis of the RNA molecules present in a sample offering insights into gene expression, alternative splicing, and also the presence of non-coding RNAs.
Offering a thorough understanding of transcriptome dynamics and gene expression, next generation sequencing (NGS-based RNA-sequencing) is a potent and revolutionary technique in genomics.
Download a Free Sample Research Report with Latest Industry Insights: https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/3898
Our Free Sample Report includes:
- Overview & introduction of market study
- Revenue and CAGR of the market
- Drivers & Restrains factors of the market
- Major key players in the market
- Regional analysis of the market with a detailed graph
- Detailed segmentation in tabular form of market
- Recent developments/news of the market
- Opportunities & Challenges of the Market
Competitive Landscape:
The NGS-Based RNA-Sequencing Market is characterized by rapid growth, technological innovation, and fierce competition. Companies are expanding their global presence, focusing on sustainability, and diversifying their service offerings to stay competitive.
Some of the Key Market Players:
- Illumina
- Thermo Fischer Scientific
- Oxford Nanopore
- Agilent Technologies, Inc.
- BGI
- Perkinelmer Inc.
- QIAGEN
- Eurofins Scientific
- F. Hoffmann-La Roche Ltd.
- Takara Bio Inc.
To Know More on Additional Market Players, Download a Free Sample Report Here: https://www.prophecymarketinsights.com/market_insight/Insight/request-pdf/3898
Analyst View:
The market for RNA sequencing is growing as genomics and personalized medicine gain more attention. Particularly in the fields of oncology, neurology, and infectious illness, researchers and physicians are using RNA-sequencing to better understand disease mechanisms, discover biomarkers, and obtain insights into gene expression.
Market Dynamics:
Drivers:
Growth in Omics Research
- A crucial part of multi-omics methods is RNA-sequencing which allows researchers to combine information from proteomics, metabolomics, transcriptomic, and genomes. Demand for RNA-sequencing thorough transcriptome analysis is rising as omics research expands.
Request for FLAT 30% Off on this Report @ https://www.prophecymarketinsights.com/market_insight/Insight/request-discount/3898
Market Trends:
Focus on Single-Cell RNA-Sequencing
- ScRNA-seq, or single-cell RNA sequencing, is becoming more popular because it makes it possible to analyze gene expression at the single-cell level. This method is being employed more in developmental biology, immunology, and cancer research, offering greater insights into cellular heterogeneity.
Segmentation:
NGS-Based RNA-Sequencing Market is segmented based on Product and Service, Technology, Application, End User, and Region.
Product and Service Insights
- This sector includes Sample Preparation Products, Sequencing Platforms and Consumables, Sequencing Services, and Data Analysis, Storage, and Management. The Sequencing Platforms & Consumables segment is expected to dominate the target market growth as these platforms include high throughput sequencers from leading manufacturers like Illumina, Thermo Fisher Scientific, and BGI are designed to process and analyze large volumes of RNA samples with high accuracy and speed.
Delivery Mode Insights
- In the target market sequencing by synthesis is the most dominant segment as involves the iterative addition of fluorescently labeled nucleotides to a DNA template strand followed by the detection of these nucleotides to determine the sequence.
End-use Insights
- In the target market expression profiling analysis is the most dominant segment as this method provides a comprehensive perspective of the transcriptome by using next-generation sequencing technology to determine which genes are expressed, to what extent, and how expression levels fluctuate between tissues, developmental phases, or disease states.
Request FREE Unlimited Customization on this Report @ https://www.prophecymarketinsights.com/market_insight/Insight/request-customization/3898
Recent Development:
- In March 2023, a package comprising Illumina products and the GenoScreen Deeplex Myc-TB assay, a targeted next-generation sequencing (NGS) test for the comprehensive and quick identification of anti-TB medication resistance, was released by Illumina Inc. and GenoScreen. This will contribute to the World Health Organization's (WHO) 2035 global tuberculosis epidemic plan.
Regional Insights
- North America: Leading research institutes, biotechnology businesses as well as pharmaceutical corporations that are at the forefront of implementing and developing NGS technologies are heavily concentrated in North America.
- Asia Pacific: This region is experiencing a surge in the biotechnology industry with a growing number of biotech startups and established companies adopting NGS technologies.
Browse Detail Report on "NGS-Based RNA-Sequencing Market Size, Share, By Product and Service (Sample Preparation Products, Sequencing Platforms and Consumables, Sequencing Services, and Data Analysis, Storage, and Management), By Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Single-molecule Real-time Sequencing, and Nanopore Sequencing), By Application (Expression Profiling Analysis, Small RNA Sequencing, De Novo Transcriptome Assembly, and Variant Calling and Transcriptome Epigenetics), By End User (Research and Academia, Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, and Other End Users), and By Region - Trends, Analysis, and Forecast till 2034" with complete TOC @ https://www.prophecymarketinsights.com/market_insight/Global-NGSBased-RNASequencing-Market-By-3898
Browse More Research Reports:
- Super Absorbent Polymer Market Size & Share Research Report, 2024-2034
- Iliac Stent Market Size & Share Research Report, 2024-2034
- Exosome Diagnostics and Therapeutics Market Size & Share Research Report, 2024-2034
- Medical Device Commercialization Services Market Size & Share Research Report, 2024-2034
About Us:
Prophecy Market Insights is a specialized market research, analytics, marketing, and business strategy, and solutions company that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. Also, we help our client to address business challenges and provide the best possible solutions to overcome them and transform their business.
Prophecy’s expertise area covers products, services, latest trends, developments, market growth factors, and challenges along with market forecasts in various business areas such as Healthcare, Pharmaceutical, Biotechnology, Information Technology (IT), Automotive, Industrial, Chemical, Agriculture, Food and Beverage, Energy, and Oil and Gas. We also offer various other services such as data mining, information management, and revenue enhancement suggestions.
Contact Us:
Prophecy Market Insights
US: 964 E. Badillo Street
#2042 Covina,
CA 91724
US toll-free: +1 860 531 2574
Rest of world: + 91 7775049802
Follow us on LinkedIn | Twitter
